Stock Price

Stamper Oil & Gas secures C$150,000 in loans, with its own chairman providing a third. Is this a vote of confidence or a sign of financial distress?

After its stock mysteriously surged over 2,000% intraday, China Pharma announced a $5M offering at a steep discount. A strategic move or a sign of strain?

Gesa Credit Union's acquisition of Willamette Valley Bank signals a major shift, blending a credit union's scale with a community bank's local roots.

Cango Inc.'s 10-for-1 share consolidation is a bid to fix its stock price, but can this financial tool truly fuel its ambitious pivot into Bitcoin and AI?

Arcturus Therapeutics heads to the Canaccord Growth Conference to spotlight its advanced mRNA platform, shifting focus from COVID vaccines to rare diseases.

Vertical Aerospace's Valo eVTOL wowed Farnborough, but this historic flight marks the start, not the end, of a complex journey through regulation and finance.

With regulatory approval secured, Hancock Whitney's $377.6M acquisition of One Florida Bank is set to reshape the state's banking landscape.

Kolon TissueGene's revolutionary knee therapy, once a beacon of hope, fails a pivotal Phase 3 trial, raising questions about its future and the broader field.

A struggling medtech firm and an AI drug developer merge. It's not just a deal; it's a new blueprint for innovation, funded by high-risk capital.

Recent SEC filings link powerhouse investor Citadel to streaming upstart FreeCast. But as we peel back the layers, a story of high-risk, high-reward emerges.

Singapore-based Ohmyhome faces a Nasdaq delisting notice. With 180 days to recover, can its radical pivot to digital marketing save it from the brink?

An institutional investor’s decisive move spotlights a €205M valuation gap in the Addiko Bank takeover, raising critical questions about M&A fairness.

Intuit faces a class-action lawsuit after a 20% stock drop. Allegations of misleading statements and $41M in insider sales put a spotlight on executive accountability.

A shareholder lawsuit against Planet Fitness alleges misleading growth plans led to a 31% stock crash, raising questions about corporate transparency.

A $17.5M write-down and a shareholder lawsuit reveal a critical lesson for tech firms: production capacity must align with market demand, or investors will pay the price.

Transcat's upcoming earnings are more than just numbers; they're a barometer for the life sciences and aerospace sectors. Can its M&A strategy sustain growth?

With its MASH drug Rezdiffra a certified blockbuster, Madrigal's upcoming Q2 report will reveal if its meteoric rise can be sustained against new rivals.

The UK SME lender reports a 50% revenue jump and soaring profits, crediting its AI platform and new FlexiPay and Card products for defying market headwinds.

As investors await Multitude AG’s mid-year results, a look at recent performance and a shifting European regulatory landscape reveals a story of strategic recalibration.

AST SpaceMobile secured $1 billion via complex convertible notes to accelerate its global network, a strategic bet that spooks investors with dilution fears.